B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Closantel

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Closantel, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

iodoquinol
7 shared targets
bithionol
11 shared targets
candesartan
7 shared targets
cetylpyridinium
10 shared targets
tribromsalan
6 shared targets
nelfinavir
8 shared targets
3345
4 shared targets
oxiconazole
8 shared targets
isotretinoin
4 shared targets
sulconazole
8 shared targets
Loading evidence profile...

This evidence profile for Closantel is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.